Literature DB >> 91538

Measurement of human proinsulin by an indirect two-site immunoradiometric assay.

S J Rainbow, J S Woodhead, D K Yue, S D Luzio, C N Hales.   

Abstract

An indirect two-site immunoradiometric assay is described for the measurement of human proinsulin in plasma. Polyethylene tubes coated with purified guinea-pig antibodies to insulin were used to extract proinsulin and insulin from plasma. Rabbit antibody to human C peptide was then added to react with the C-peptide moiety of the bound proinsulin. The uptake of this antibody was measured by the subsequent binding of 125I-sheep antibody to rabbit IgG. The binding of radioactivity to the tubes was a function of the proinsulin concentration in the sample. The sensitivity of the assay was 0.006 pmol/ml. Only 200 microliters of plasma was required in the assay and the 125I-labelled antibody was produced from readily available reagents. The polyethylene tubes remained stable for at least 5 months after coating. The mean fasting proinsulin level was 0.009 pmol/ml in sixteen normal subjects and 0.025 pmol/ml in twelve maturity onset diabetics. Oral glucose produced an 8 fold increase in proinsulin concentration but a decline in the plasma proinsulin/insulin molar ratio. Four patients with insulinoma had extremely elevated proinsulin levels and proinsulin/insulin ratios.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91538     DOI: 10.1007/BF01235859

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Plasma proinsulin in patients with functioning pancreatic islet cell tumors.

Authors:  B M Sherman; S Pek; S S Fajans; J C Floyd; J W Conn
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

4.  Direct measurement of plasma proinsulin in normal and diabetic subjects.

Authors:  W C Duckworth; A E Kitabchi
Journal:  Am J Med       Date:  1972-10       Impact factor: 4.965

5.  Immunoradiometric assay of parathyroid hormone.

Authors:  G M Addison; C N Hales; J S Woodhead; J L O'Riordan
Journal:  J Endocrinol       Date:  1971-03       Impact factor: 4.286

6.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

7.  Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme.

Authors:  A E Kitabchi; W C Duckworth; J S Brush; M Heinemann
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

8.  Insulin biosynthesis: evidence for a precursor.

Authors:  D F Steiner; D Cunningham; L Spigelman; B Aten
Journal:  Science       Date:  1967-08-11       Impact factor: 47.728

9.  Two-site assay of bovine parathyroid hormone.

Authors:  J S Woodhead; S J Davies; D Lister
Journal:  J Endocrinol       Date:  1977-05       Impact factor: 4.286

10.  Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors.

Authors:  P Gorden; B Sherman; J Roth
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  10 in total

Review 1.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Indirect two-site immunoradiometric assay of rat and mouse proinsulin.

Authors:  D K Yue; O M Gibby; S D Luzio; N Yanaihara; C N Hales
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

3.  Immunological techniques in diabetes research: 14 years on.

Authors:  C N Hales
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

4.  Islet amyloid in Type 2 (non-insulin-dependent) diabetes is related to insulin.

Authors:  P Westermark; E Wilander
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

5.  A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).

Authors:  H Yano; N Kitano; M Morimoto; K S Polonsky; H Imura; Y Seino
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Growth hormone and metasomatotrophic diabetes: effects on insulin and proinsulin of serum and pancreas in dogs.

Authors:  J Pierluissi; J Campbell
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

7.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

8.  Biochemical and clinical implications of proinsulin conversion intermediates.

Authors:  B D Given; R M Cohen; S E Shoelson; B H Frank; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Human proinsulin standards.

Authors:  V Kruse; L G Heding; K H Jørgensen; B Tronier; M Christensen; L Thim; B H Frank; M A Root; R M Cohen; A H Rubenstein
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

10.  Hypersecretion of proinsulin in thyrotoxicosis.

Authors:  L Sestoft; L G Heding
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.